# PMV Pharmaceuticals

> PMV Pharmaceuticals is a VC fund backing Health Care and Biotechnology. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Redwood City, United States
- Total investments: 2
- Last investment: Sep 2015
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/pmv-pharmaceuticals-inc.
- Website: http://www.pmvpharma.com/

PMV Pharmaceuticals is a VC fund in Redwood City focused on Health Care and Biotechnology. PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

## Contacts

5 contacts available for PMV Pharmaceuticals. Shizune tracks 5 team members at PMV Pharmaceuticals. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/pmv-pharmaceutcals-inc?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 1 | 50% |
| The Netherlands | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Arnold Levine | Co-Founder | 0 | — |
| David Mack | President & CEO | 0 | — |
| Leila Alland | Chief Medical Officer | 0 | — |
| Thomas Shenk | Co-Founder & Member, Scientific Advisory Board | 0 | — |
| Tim Smith | SVP, Head of Corporate Development | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Apitope | Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, Factor VIII intolerance and uveitis. The company, whose first product candidate is licensed to Merck Serono, will now progress its remaining portfolio of productcandidates developed with its proprietary platform technology. | $13.2M | Series B | Sep 29, 2015 |  |
| FF Pharma | FF Pharma, a biopharmaceutical company, develops anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases like primary biliary cirrhosis and Crohn’s disease. The functions of CD40 in immune regulation suggest that the CD40 pathway may play a role in diseases in which anomalous immune responses, e.g. autoantibodyproduction or chronic inflammation, are a feature. | $4.2M | Series A | Jan 23, 2013 |  |

2 of 2 investments shown.

## Co-investors
- [Limburgse Reconversie Maatschappij](https://shizune.co/investors/profile/limburgse-reconversie-maatschappij) — VC Fund, 2 deals together
- [Vesalius Biocapital Partners](https://shizune.co/investors/profile/vesalius-biocapital-partners) — VC Fund, 2 deals together
- Arthurian Life Sciences — VC Fund, 1 deal together
- Wyvern Seed Fund — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does PMV Pharmaceuticals invest in?

PMV Pharmaceuticals invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact PMV Pharmaceuticals?

Public channels for PMV Pharmaceuticals include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at PMV Pharmaceuticals?

The team at PMV Pharmaceuticals includes Arnold Levine (Co-Founder), David Mack (President & CEO) and Leila Alland (Chief Medical Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co